Skip to main content
OpenTrials

Clinical trial condition

Synostosis

Explore clinical trials studying Synostosis. Study availability and eligibility vary by location and protocol.

66 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Synostosis trial results

Active, not recruiting

Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations

NCT06160752

Conditions
Acrocephalosyndactylia, Adenocarcinoma, Bone Diseases, +24 more
Locations
  • University of California San Francisco (UCSF) San Francisco, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • The Ohio State University Columbus, Ohio, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, not recruiting

Early Genetic Identification of Obesity

NCT06239064

Conditions
Abnormalities, Multiple, Bardet-Biedl Syndrome, Body Weight, +40 more
Locations
  • Universitätsklinikum Aachen (RWTH) Aachen, Germany
  • KJF Klinik Josefinum Augsburg, Germany
  • Universitätsklinikum Augsburg - Klinik für Kinder- und Jugendmedizin Augsburg, Germany
  • Universitätsklinikum Freiburg Bad Krozingen, Germany
View all 37 locations
View Trial Details
Active, not recruiting

Network Of Clinical Research Studies On Craniosynostosis, Skull Malformations With Premature Fusion Of Skull Bones

NCT03025763

Conditions
Bone Diseases, Bone Diseases, Developmental, Congenital Abnormalities, +8 more
Locations
  • The International Craniosynostosis Consortium at University of California at Davis Davis, California, United States
  • Yale University Hartford, Connecticut, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • National Birth Defects Prevention Study at University of Iowa Iowa City, Iowa, United States
View all 20 locations
View Trial Details
Completed

A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer

NCT04572295

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +16 more
Locations
  • Eisai Trial Site 11 Nagoya, Aichi-ken, Japan
  • Eisai Trial Site 6 Kashiwa, Chiba, Japan
  • Eisai Trial Site 9 Matsuyama, Ehime, Japan
  • Eisai Trial Site 5 Yokohama, Kanagawa, Japan
View Trial Details

Related conditions